Bioresorbable vascular scaffold versus everolimus ‐eluting stents or drug eluting balloon for the treatment of coronary in‐stent restenosis: 1‐Year follow‐up of a propensity score matching comparison (the BIORESOLVE‐ISR Study)

Catheterization and Cardiovascular Interventions, EarlyView.

https://www.onlinelibrary.wiley.com/doi/abs/10.1002/ccd.27473?af=R

Source: Catheterization and Cardiovascular Interventions - January 22, 2018 Category: Cardiovascular & Thoracic Surgery Authors: ElisabettaMoscarellaMD , AkihitoTanakaMD , AlfonsoIelasiMD , BernardoCorteseMD , SebastianCoscarelliMD , Maria CarmenDe AngelisMD , DavidePirainoMD , AzeemLatibMD , GiuliettaGrigisMD , RenatomariaBianchiMD , DarioBuccheriM Source Type: research

More News: Cardiology | Cardiovascular | Heart | Study